Production

Fresenius Kabi produces Lactulose at its state-of-the-art facilities in Linz, Austria, and Vicchio, Italy. These facilities are approved by the FDA and other international health agencies, ensuring the highest standards of quality and safety.

Our patented, solvent-free process utilizes environmentally friendly technology, reflecting our commitment to sustainability.

Aligned with our “committed to life” philosophy, we continuously enhance our products to better serve patients and protect the planet.

Linz Plant - Austria

FDA and international health authorities approved facility

The process for producing lactulose was developed in Linz laboratories and patented in 1969.

Pharmaceutical production on site enables the direct processing of lactulose in bulk form into finished products.

A high degree of automation and an environmentally friendly process developed in-house support consistently high quality and a high degree of flexibility in the production process.

Lactulose production runs 24 hours a day, seven days a week.

Vicchio Plant - Italy

FDA and international health authorities approved facility

The production of lactulose as an active pharmaceutical ingredient (API) in both liquid and solid form to the highest quality standards is modern and state-of-the-art.

The plant in Italy is the only one in Europe that produces lactulose crystals according to the EP specification, using a unique and patented process.

The HACCP concept has been introduced for the production of lactulose for use in food and animal feed. Lactulose crystals are highly pure and of excellent quality, which makes them a unique product.